SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Microcide Pharmaceuticals (MCDE)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Czechsinthemail who wrote (61)5/29/1997 3:18:00 PM
From: scaram(o)uche   of 186
 
CellPro openly challenged a patent that Applied Immune Sciences (now a part of Rhone-Poulenc Rorer) chose to license. I had just done a stint at SyStemix, and the patent and issues surrounding it were very much on my radar. The CPRO stance seemed, to me, to be arrogant. This is not hindsight..... I considered their strategy to have been unwise, from the beginning.

What companies do I respect for patents? Many, including MCDE (but, again, it's a very early story at MCDE). Try looking at PDLI. GNE has used patents for text-book strategic maneuvering. Murky and difficult to enforce? While I don't see them as murky, I do think that you will enjoy following the TKTX versus AMGN story as it unfolds.

Your choice to discuss CPRO is of interest. It is of primary importance that an investor first determine that his company actually has rights to practice a relevant art. For years, informed investors have looked at CPRO and said "huh?". Beware of moustaches that grow smaller as objectives slip away.

A call to IR at MCDE will perhaps yield a complete discussion regarding patent strategy and stance. If you call them, please let us know what they have to say.

If you feel that biotech patents are murky and difficult to enforce, why are you investing in the sector? Patents are all we've got. :-)

Cheers! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News